Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid Concentrate
Dialysate Concentrate For Hemodialysis (Liquid Or Powder). 510(k) K192017, from Fresenius Medical Care Renal Therapies Group, LLC (Waltham, MA). Product code KPO, class 2.
As of Nov 19, 2026, K192017 is an FDA 510(k) held by Fresenius Medical Care Renal Therapies Group, LLC, substantially equivalent on Apr 24, 2020 after 270 days, with 6 recalls tied to it in FDA's recall database.
- Review time: 270 days
- Recalls: 6
- Cited as a predicate by: 1 device
Citrasate® Liquid Acid Concentrate is indicated for use in patients undergoing extracorporeal bicarbonate hemodialysis for acute and chronic renal failure. Citrasate® Liquid Acid Concentrate is intended to be used as one component in the preparation of dialysate in a 3-stream proportioning hemodialysis machine according to a physician's prescription.
- Citrasate Dialysate Acid Concentrate Liquid, Models CS-1XXX-XX, Cs-Xxx-Xx, CS-3XXX-XXK000792 · Advanced Renal Technologies, Inc. · Jun 8, 2000
- Dialysol-Acid Concentrate Liquid, Granusol-Acid Concentrate Powder, Renalsol-Acetate Concentrate Liquid & Powder, BiosolK981043 · Solution Technologies · May 26, 1998
- Citrasate Liquid Acid Concentrate, NaturaLyte Liquid Acid ConcentrateK212620 · Fresenius Medical Care Renal Therapies Group, LLC · May 12, 2022
| Jul 14, 2026 | Z-3093-2026, Z-3092-2026Complaints of blue-green discoloration in product | Open |
| Jun 1, 2022 | Z-1311-2022The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging. Leaks can lead to biological contamination and therefore an increased risk of potential bloodstream… | Terminated |
| May 31, 2022 | Z-1371-2022, Z-1370-2022Alternate Bottle Caps labeled with "Sealed for your Protection" on the foil not qualified for use | Open |
| Apr 28, 2021 | Z-2086-2021Exposed to freezing temperatures due to refrigerated truck malfunctions | Terminated |
- Nipro Dry Acid Concentrate MixerK260799 · Nipro Technical Solutions, Incoporated · Aug 19, 2026
- NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)K253462 · Fresenius Medical Care Renal Therapies Group, LLC · Jan 29, 2026
- Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G);…K252180 · Fresenius Medical Care Renal Therapies Group, LLC · Sep 9, 2025
- Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby Dialysate RFP-407 (RFP-407-G);…K243786 · Fresenius Medical Care Renal Therapies Group, LLC · Apr 4, 2025
- HemoCare Bicarbonate Concentrate Set (BCS)K240920 · Deka Research and Development · Jul 12, 2024
- pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW 400 (F00012070)K233950 · Fresenius Medical Care Renal Therapies Group, LLC · May 10, 2024
- NxStage PureFlow SolutionK233213 · Nxstage Medical, Inc. · Jan 18, 2024
- pureFLOW 402, pureFLOW 400, pureFLOW 406, pureFLOW 401, pureFLOW 502, pureFLOW 504K233159 · Fresenius Medical Care Renal Therapies Group, LLC · Dec 1, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 29, 2019
- Review panel
- Gastroenterology, Urology
- Regulation
- 21 CFR 876.5820
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files